Vor Common Stock Shares Outstanding vs Other Current Assets Analysis

VOR Stock  USD 1.27  0.43  51.19%   
Vor Biopharma financial indicator trend analysis is much more than just breaking down Vor Biopharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vor Biopharma is a good investment. Please check the relationship between Vor Biopharma Common Stock Shares Outstanding and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Common Stock Shares Outstanding vs Other Current Assets

JavaScript chart by amCharts 3.21.1520142016201820202022202410M15M20M25M30M35M40M45M50M55M60M 10K100K1M10M
JavaScript chart by amCharts 3.21.15Common Stock Shares Outstandingtotal: 293.2MOther Current Assetstotal: 21.4M

Common Stock Shares Outstanding vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vor Biopharma Common Stock Shares Outstanding account and Other Current Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Vor Biopharma's Common Stock Shares Outstanding and Other Current Assets is 0.69. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Vor Biopharma, assuming nothing else is changed. The correlation between historical values of Vor Biopharma's Common Stock Shares Outstanding and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Vor Biopharma are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Common Stock Shares Outstanding i.e., Vor Biopharma's Common Stock Shares Outstanding and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.69
Relationship DirectionPositive 
Relationship StrengthSignificant

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most indicators from Vor Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vor Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.As of 12/28/2024, Selling General Administrative is likely to drop to about 18.1 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 103.9 M
 2021 2022 2023 2024 (projected)
Reconciled Depreciation1.4M2.5M3.2M3.4M
Total Operating Expenses69.0M93.4M126.0M63.3M

Vor Biopharma fundamental ratios Correlations

0.890.810.761.00.880.930.8-0.58-0.820.750.850.931.00.780.930.980.910.920.940.92-0.371.0-0.010.990.45
0.890.830.680.870.820.960.9-0.28-0.880.750.620.960.850.930.960.790.870.920.760.96-0.50.850.150.850.41
0.810.830.840.780.710.880.83-0.43-0.830.820.720.90.770.880.910.70.770.920.60.87-0.50.770.390.760.32
0.760.680.840.720.750.850.48-0.18-0.790.490.510.850.720.60.850.660.770.90.680.86-0.460.72-0.010.70.73
1.00.870.780.720.880.90.79-0.61-0.80.750.870.911.00.760.910.990.90.890.950.9-0.351.0-0.031.00.42
0.880.820.710.750.880.840.66-0.3-0.940.50.670.840.870.750.830.860.990.830.890.85-0.70.87-0.30.870.65
0.930.960.880.850.90.840.8-0.3-0.890.730.651.00.890.851.00.830.890.990.821.0-0.450.890.10.880.55
0.80.90.830.480.790.660.8-0.52-0.730.850.730.830.770.960.830.720.720.770.610.8-0.380.770.390.770.04
-0.58-0.28-0.43-0.18-0.61-0.3-0.3-0.520.15-0.6-0.89-0.33-0.63-0.36-0.34-0.67-0.31-0.32-0.52-0.28-0.17-0.63-0.22-0.640.27
-0.82-0.88-0.83-0.79-0.8-0.94-0.89-0.730.15-0.58-0.57-0.89-0.78-0.85-0.88-0.74-0.96-0.88-0.74-0.90.8-0.780.07-0.77-0.61
0.750.750.820.490.750.50.730.85-0.6-0.580.810.760.740.750.780.680.590.740.50.71-0.270.740.620.74-0.13
0.850.620.720.510.870.670.650.73-0.89-0.570.810.680.880.640.690.890.690.670.750.64-0.240.880.190.880.03
0.930.960.90.850.910.841.00.83-0.33-0.890.760.680.90.871.00.840.90.990.811.0-0.460.90.120.890.53
1.00.850.770.721.00.870.890.77-0.63-0.780.740.880.90.750.90.990.90.880.950.89-0.341.0-0.041.00.42
0.780.930.880.60.760.750.850.96-0.36-0.850.750.640.870.750.860.690.80.830.620.85-0.550.750.270.740.24
0.930.960.910.850.910.831.00.83-0.34-0.880.780.691.00.90.860.830.880.990.80.99-0.450.890.170.890.5
0.980.790.70.660.990.860.830.72-0.67-0.740.680.890.840.990.690.830.870.820.970.83-0.30.99-0.130.990.41
0.910.870.770.770.90.990.890.72-0.31-0.960.590.690.90.90.80.880.870.880.880.9-0.70.89-0.190.890.62
0.920.920.920.90.890.830.990.77-0.32-0.880.740.670.990.880.830.990.820.880.790.99-0.460.880.130.870.56
0.940.760.60.680.950.890.820.61-0.52-0.740.50.750.810.950.620.80.970.880.790.82-0.310.95-0.340.950.59
0.920.960.870.860.90.851.00.8-0.28-0.90.710.641.00.890.850.990.830.90.990.82-0.470.890.070.880.58
-0.37-0.5-0.5-0.46-0.35-0.7-0.45-0.38-0.170.8-0.27-0.24-0.46-0.34-0.55-0.45-0.3-0.7-0.46-0.31-0.47-0.340.12-0.33-0.42
1.00.850.770.721.00.870.890.77-0.63-0.780.740.880.91.00.750.890.990.890.880.950.89-0.34-0.041.00.42
-0.010.150.39-0.01-0.03-0.30.10.39-0.220.070.620.190.12-0.040.270.17-0.13-0.190.13-0.340.070.12-0.04-0.04-0.62
0.990.850.760.71.00.870.880.77-0.64-0.770.740.880.891.00.740.890.990.890.870.950.88-0.331.0-0.040.4
0.450.410.320.730.420.650.550.040.27-0.61-0.130.030.530.420.240.50.410.620.560.590.58-0.420.42-0.620.4
Click cells to compare fundamentals

Vor Biopharma Account Relationship Matchups

Vor Biopharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.8M75.9M242.6M299.4M198.1M151.6M
Other Current Liab1.5M6.1M4.9M4.8M7.1M4.8M
Total Current Liabilities2.2M10.2M10.2M13.1M15.6M10.8M
Total Stockholder Equity7.6M48.3M216.3M250.6M150.7M122.2M
Net Tangible Assets(17.4M)(59.1M)216.3M250.6M288.2M302.6M
Property Plant And Equipment Net728K21.8M22.5M57.1M50.1M27.9M
Net Debt(6.5M)(30.2M)(101.8M)(18.8M)4.3M4.5M
Retained Earnings(17.9M)(61.2M)(130.1M)(222.2M)(340.1M)(323.1M)
Accounts Payable693K2.4M1.5M1.8M815K1.3M
Cash6.5M48.5M119.8M57.7M31.4M48.5M
Non Current Assets Total2.3M26.8M28.2M62.4M57.3M32.5M
Cash And Short Term Investments6.5M48.5M207.5M230.2M137.2M115.7M
Common Stock Shares Outstanding37.1M37.1M37.2M39.6M67.2M41.0M
Liabilities And Stockholders Equity9.8M75.9M242.6M299.4M198.1M151.6M
Non Current Liabilities Total693K17.4M16.2M35.6M31.8M18.7M
Other Current Assets205K567K6.9M6.7M3.6M3.3M
Other Stockholder Equity458K2.2M346.4M473.6M490.9M515.4M
Total Liab2.2M27.6M26.3M48.8M47.4M29.3M
Net Invested Capital(17.4M)(59.1M)216.3M250.6M150.7M98.8M
Property Plant And Equipment Gross728K21.8M24.6M61.7M58.2M30.6M
Total Current Assets7.5M49.1M214.4M237.0M140.8M119.1M
Capital Stock25.1M107.3M4K7K6.3K6.0K
Net Working Capital5.4M38.9M204.2M223.8M125.2M108.3M
Property Plant Equipment728K21.8M6.9M12.6M14.5M9.3M

Pair Trading with Vor Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vor Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Vor Stock

  0.7DTIL Precision BioSciencesPairCorr
  0.68VALN Valneva SE ADRPairCorr
  0.65DOMH Dominari HoldingsPairCorr
  0.64ME 23Andme HoldingPairCorr
  0.63VINC Vincerx PharmaPairCorr
The ability to find closely correlated positions to Vor Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vor Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vor Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vor Biopharma to buy it.
The correlation of Vor Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vor Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vor Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vor Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.

Trending Assets

DSGN
Design Therapeutics
6.25  -0.24  -3.7 
BOLT
Bolt Biotherapeutics
0.52  0.01  1.96 
NRIX
Nurix Therapeutics
19.11  -0.82  -4.11 
THRX
Theseus Pharmaceuticals
3.71  0.14  3.92 
NUVL
Nuvalent
80.30  -1.76  -2.14 
CGEM
Cullinan Oncology LLC
12.02  -0.88  -6.82 
LYRA
Lyra Therapeutics
0.19  0.01  5.56 
AUTL
Autolus Therapeutics
2.26  -0.04  -1.74 
DAWN
Day One Biopharmaceu
12.87  -0.03  -0.23 
STTK
Shattuck Labs
1.24  0.13  11.71 
TALS
Talaris Therapeutics
2.98  -0.1  -3.25 
ACLX
Arcellx
79.02  1.44  1.86 
FHTX
Foghorn Therapeutics
4.82  -0.27  -5.3 
ERAS
Erasca Inc
2.62  0.05  1.95 
ACET
Adicet Bio
0.93  -0.03  -3.12 
EWTX
Edgewise Therapeutics
28.74  -0.92  -3.1 
KNSA
Kiniksa Pharmaceuticals
20.01  -0.1  -0.5 
VTYX
Ventyx Biosciences
2.38  0.05  2.15 
GLUE
Monte Rosa Therapeutics
7.06  -0.16  -2.22 
KYMR
Kymera Therapeutics
40.11  -1.91  -4.55